SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on December 14, 2020. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses the scheduling of a presentation by Kenneth L. Londoner, Executive Chairman, at the 13th Annual LD Micro Main Event Conference on December 14, 2020.
Guidance, Outlook, and Risks
The Company explicitly states it undertakes no obligation to update, supplement, or amend the presentation materials attached as Exhibit 99.1. The information provided is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. The Company notes that furnishing this information is not intended to constitute a determination that the information is material or required by Regulation FD.
Key Facts for Investor Verification
- The filing announces a live virtual presentation by the Executive Chairman on December 14, 2020.
- Exhibit 99.1 contains the presentation slides, which are furnished but not filed.
- The Company disclaims any obligation to update the information contained in the presentation.
- No financial data or operational metrics are included in this specific 8-K filing.